
Discovery and Pre-Clinical Phases

Discovery and Pre-Clinical Phases is organized by Drug Information Association (DIA). This Conference has been approved for a maximum of 1 contact hour or .1 CEUs.
Release Date: May 12, 2021
Expiration Date: May 12, 2024
Who should attend?
This module is designed for individuals who are new to, or changing roles in, the pharmaceutical and biotechnology industries. The module will also benefit professionals who work in the areas of:
• Clinical Research
• Project Management
• Administrative Support
• Quality Assurance
• Regulatory Affairs
• Manufacturing
• Medical writing
• Business Support
Course Description:
The Discovery and Pre-Clinical Phases module (formerly titled Discovery and Preclinical Testing Phases) is part of the DIA Drug Development and Lifecycle Management eLearning Program. In this module, learners focus on how companies advance potential drug candidates through the earliest stages of research, from therapeutic target to readiness for clinical studies.
Learning objectives:
Upon completion of this module, learners should be able to:
• Describe discovery activities
• Explain how toxicology studies are conducted
• Discuss drug substance production and drug product formulation activities
• Describe the functions of good manufacturing and laboratory practices
• Explain how biomarkers and surrogate endpoints are used